{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:49:35Z","timestamp":1760953775104},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T00:00:00Z","timestamp":1347321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s10014-012-0117-x","type":"journal-article","created":{"date-parts":[[2012,9,10]],"date-time":"2012-09-10T09:36:12Z","timestamp":1347269772000},"page":"160-166","source":"Crossref","is-referenced-by-count":14,"title":["Reduced expression of ELAVL4 in male meningioma patients"],"prefix":"10.1007","volume":"30","author":[{"given":"Robert","family":"Stawski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylwester","family":"Piaskowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Stoczynska-Fidelus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystyna","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Bienkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Zakrzewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Witusik-Perkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz J.","family":"Jaskolski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Och","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wielislaw","family":"Papierz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Sikorska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Rieske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel P.","family":"Liberski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,11]]},"reference":[{"key":"117_CR1","doi-asserted-by":"crossref","unstructured":"Collins VP (2004) Brain tumours classification and genes. J Neurol Neurosurg Psychiatry 75:ii2\u2013ii11","DOI":"10.1136\/jnnp.2004.040337"},{"key":"117_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cancergencyto.2008.01.020","volume":"183","author":"K Wozniak","year":"2008","unstructured":"Wozniak K, Piaskowski S, Gresner SM et al (2008) BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region. Cancer Genet Cytogenet 183:14\u201320","journal-title":"Cancer Genet Cytogenet"},{"key":"117_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","volume":"64","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479\u2013489","journal-title":"J Neuropathol Exp Neurol"},{"key":"117_CR4","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1038\/sj.onc.1202863","volume":"18","author":"EN Imyanitov","year":"1999","unstructured":"Imyanitov EN, Birrell GW, Filippovich I et al (1999) Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target. Oncogene 18:4640\u20134642","journal-title":"Oncogene"},{"key":"117_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/gcc.2870140305","volume":"14","author":"RA Lothe","year":"1995","unstructured":"Lothe RA, Andersen SN, Hofstad B et al (1995) Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosom Cancer 14:182\u2013188","journal-title":"Genes Chromosom Cancer"},{"key":"117_CR6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2006.11.052","volume":"128","author":"A Bagchi","year":"2007","unstructured":"Bagchi A, Papazoglu C, Wu Y et al (2007) CHD5 is a tumor suppressor at human 1p36. Cell 128:459\u2013475","journal-title":"Cell"},{"key":"117_CR7","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1634\/theoncologist.12-10-1225","volume":"12","author":"MD Tabernero","year":"2007","unstructured":"Tabernero MD, Espinosa AB, Maillo A et al (2007) Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas. Oncologist 12:1225\u20131236","journal-title":"Oncologist"},{"key":"117_CR8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1750-3639.2009.00356.x","volume":"20","author":"Y Lee","year":"2010","unstructured":"Lee Y, Liu J, Patel S et al (2010) Genomic landscape of meningiomas. Brain Pathol 20:751\u2013762","journal-title":"Brain Pathol"},{"key":"117_CR9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cancergencyto.2005.02.009","volume":"162","author":"S Piaskowski","year":"2005","unstructured":"Piaskowski S, Rieske P, Szybka M et al (2005) GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis. Cancer Genet Cytogenet 162:63\u201367","journal-title":"Cancer Genet Cytogenet"},{"key":"117_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<255::AID-GCC11>3.0.CO;2-2","volume":"24","author":"I Bi\u00e8che","year":"1999","unstructured":"Bi\u00e8che I, Khodja A, Lidereau R (1999) Deletion mapping of chromosomal region 1p32-pter in primary breast cancer. Genes Chromosom Cancer 24:255\u2013263","journal-title":"Genes Chromosom Cancer"},{"key":"117_CR11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<354::AID-GCC7>3.0.CO;2-O","volume":"25","author":"RC Millikan","year":"1999","unstructured":"Millikan RC, Ingles SA, Diep AT et al (1999) Linkage analysis and loss of heterozygosity for chromosome arm 1p in familial breast cancer. Genes Chromosom Cancer 25:354\u2013361","journal-title":"Genes Chromosom Cancer"},{"key":"117_CR12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0016-5085(97)70169-0","volume":"113","author":"OA Ogunbiyi","year":"1997","unstructured":"Ogunbiyi OA, Goodfellow PJ, Gagliardi G et al (1997) Prognostic value of chromosome 1p allelic loss in colon cancer. Gastroenterology 113:761\u2013766","journal-title":"Gastroenterology"},{"key":"117_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/gcc.20268","volume":"45","author":"M Aarts","year":"2006","unstructured":"Aarts M, Dannenberg H, deLeeuw RJ et al (2006) Microarray-based CGH of sporadic and syndrome-related pheochromocytomas using a 0.1\u20130.2\u00a0Mb bacterial artificial chromosome array spanning chromosome arm 1p. Genes Chromosom Cancer 45:83\u201393","journal-title":"Genes Chromosom Cancer"},{"key":"117_CR14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2867-6-4","volume":"6","author":"F Grizzi","year":"2006","unstructured":"Grizzi F, Chiriva-Internati M (2006) Cancer: looking for simplicity and finding complexity. Cancer Cell Int 6:4","journal-title":"Cancer Cell Int"},{"key":"117_CR15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1593\/neo.08718","volume":"10","author":"KL Gorringe","year":"2008","unstructured":"Gorringe KL, Choong DY, Williams LH et al (2008) Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer. Neoplasia 10:1253\u20131258","journal-title":"Neoplasia"},{"key":"117_CR16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1158\/1078-0432.CCR-05-1431","volume":"12","author":"KO Henrich","year":"2006","unstructured":"Henrich KO, Fischer M, Mertens D et al (2006) Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients. Clin Cancer Res 12:131\u2013138","journal-title":"Clin Cancer Res"},{"key":"117_CR17","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1349-7006.2009.01138.x","volume":"100","author":"C Lou","year":"2009","unstructured":"Lou C, Du Z, Yang B et al (2009) Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin. Cancer Sci 100:996\u20131004","journal-title":"Cancer Sci"},{"key":"117_CR18","first-page":"483","volume":"26","author":"HJ Kim","year":"2005","unstructured":"Kim HJ, Lotan R (2005) Identification of protein modulation by the synthetic retinoid CD437 in lung carcinoma cells using high throughput immunoblotting. Int J Oncol 26:483\u2013491","journal-title":"Int J Oncol"},{"key":"117_CR19","first-page":"1015","volume":"23","author":"M Bj\u00f8rling-Poulsen","year":"2003","unstructured":"Bj\u00f8rling-Poulsen M, Seitz G, Guerra B et al (2003) The pro-apoptotic FAS-associated factor 1 is specifically reduced in human gastric carcinomas. Int J Oncol 23:1015\u20131023","journal-title":"Int J Oncol"},{"key":"117_CR20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/(SICI)1097-0215(19960904)67:5<709::AID-IJC20>3.0.CO;2-Z","volume":"67","author":"T Takeuchi","year":"1996","unstructured":"Takeuchi T, Sasaki Y, Ueki T et al (1996) Modulation of growth and apoptosis response in PC-3 and LNCAP prostate-cancer cell lines by Fas. Int J Cancer 67:709\u2013714","journal-title":"Int J Cancer"},{"key":"117_CR21","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/carcin\/bgm083","volume":"28","author":"MV Guijarro","year":"2007","unstructured":"Guijarro MV, Leal JF, Fominaya J et al (2007) MAP17 overexpression is a common characteristic of carcinomas. Carcinogenesis 28:1646\u20131652","journal-title":"Carcinogenesis"},{"key":"117_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2007) The WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97\u2013109","journal-title":"Acta Neuropathol"},{"key":"117_CR23","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","volume":"30","author":"MW Pfaffl","year":"2002","unstructured":"Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36","journal-title":"Nucleic Acids Res"},{"key":"117_CR24","unstructured":"geNorm program. Available at: http:\/\/medgen.ugent.be\/~jvdesomp\/genorm\/"},{"key":"117_CR25","unstructured":"BestKeeper program. Available at: http:\/\/www.gene-quantification.de\/bestkeeper.html"},{"key":"117_CR26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1158\/1078-0432.1119.11.3","volume":"11","author":"V Barbashina","year":"2005","unstructured":"Barbashina V, Salazar P, Holland EC et al (2005) Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 11:1119\u20131128","journal-title":"Clin Cancer Res"},{"key":"117_CR27","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1101\/gad.1648608","volume":"22","author":"S Schlisio","year":"2008","unstructured":"Schlisio S, Kenchappa RS, Vredeveld CW et al (2008) The kinesin KIF1B\u03b2 acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev 22:884\u2013893","journal-title":"Genes Dev"},{"key":"117_CR28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.onc.1210675","volume":"27","author":"ER Okawa","year":"2008","unstructured":"Okawa ER, Gotoh T, Manne J et al (2008) Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas. Oncogene 27:803\u2013810","journal-title":"Oncogene"},{"key":"117_CR29","doi-asserted-by":"crossref","first-page":"24426","DOI":"10.1074\/jbc.M802316200","volume":"283","author":"AK Munirajan","year":"2008","unstructured":"Munirajan AK, Ando K, Mukai A et al (2008) KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J Biol Chem 283:24426\u201324434","journal-title":"J Biol Chem"},{"key":"117_CR30","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1158\/1055-9965.EPI-08-0548","volume":"17","author":"GH Piao","year":"2008","unstructured":"Piao GH, Piao WH, He Y et al (2008) Hyper-methylation of RIZ1 tumor suppressor gene is involved in the early tumorigenesis of hepatocellular carcinoma Cancer. Epidemiol Biomarkers Prev 17:3567\u20133572","journal-title":"Epidemiol Biomarkers Prev"},{"key":"117_CR31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/nbdi.2000.0376","volume":"8","author":"DH Gutmann","year":"2001","unstructured":"Gutmann DH, Hirbe AC, Huang ZY et al (2001) The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol Dis 8:266\u2013278","journal-title":"Neurobiol Dis"},{"key":"117_CR32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0969-9961(03)00071-8","volume":"13","author":"VA Robb","year":"2003","unstructured":"Robb VA, Li W, Gascard P et al (2003) Identification of a third protein 4.1 tumor suppressor, protein 4.1R, in meningioma pathogenesis. Neurobiol Dis 13:191\u2013202","journal-title":"Neurobiol Dis"},{"key":"117_CR33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1541-7786.MCR-07-0005","volume":"6","author":"R Malaguarnera","year":"2008","unstructured":"Malaguarnera R, Vella V, Pandini G et al (2008) TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation. Mol Cancer Res 6:64\u201367","journal-title":"Mol Cancer Res"},{"key":"117_CR34","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1365-2362.2001.00892.x","volume":"31","author":"S Huang","year":"2001","unstructured":"Huang S, Lichtenauer UD, Pack S et al (2001) Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas. Eur J Clin Invest 31:907\u2013914","journal-title":"Eur J Clin Invest"},{"key":"117_CR35","first-page":"109","volume":"15","author":"GL Jiang","year":"2000","unstructured":"Jiang GL, Huang S (2000) The yin-yang of PR-domain family genes in tumorigenesis. Histol Histopathol 15:109\u2013117","journal-title":"Histol Histopathol"},{"key":"117_CR36","first-page":"7619","volume":"63","author":"KC Kim","year":"2003","unstructured":"Kim KC, Geng L, Huang S (2003) Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res 63:7619\u20137623","journal-title":"Cancer Res"},{"key":"117_CR37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.cdd.4400995","volume":"9","author":"T Stiewe","year":"2002","unstructured":"Stiewe T, Putzer BM (2002) Role of p73 in malignancy: tumor suppressor or oncogene. Cell Death Differ 9:237\u2013245","journal-title":"Cell Death Differ"},{"key":"117_CR38","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.cdd.4401622","volume":"12","author":"M Marabese","year":"2005","unstructured":"Marabese M, Marchini S, Sabatino MA et al (2005) Effects of inducible overexpression of DNp73alpha on cancer cell growth and response to treatment in vitro and in vivo. Cell Death Differ 12:805\u2013814","journal-title":"Cell Death Differ"},{"key":"117_CR39","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1158\/1078-0432.CCR-05-2573","volume":"12","author":"SS Liu","year":"2006","unstructured":"Liu SS, Chan KY, Cheung AN et al (2006) Expression of deltaNp73 and TAp73alpha independently associated with radiosensitivities and prognoses in cervical squamous cell carcinoma. Clin Cancer Res 12:3922\u20133927","journal-title":"Clin Cancer Res"},{"key":"117_CR40","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.tibs.2003.10.004","volume":"28","author":"G Melino","year":"2003","unstructured":"Melino G, Lu X, Gasco M et al (2003) Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci 28:663\u2013670","journal-title":"Trends Biochem Sci"},{"key":"117_CR41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0165-4608(03)00244-9","volume":"148","author":"J Lomas","year":"2004","unstructured":"Lomas J, Ami\u00f1oso C, Gonzalez-Gomez P et al (2004) Methylation status of TP73 in meningiomas. Cancer Genet Cytogenet 148:148\u2013151","journal-title":"Cancer Genet Cytogenet"},{"key":"117_CR42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/1541-7786.371.2.7","volume":"2","author":"UM Moll","year":"2004","unstructured":"Moll UM, Slade N (2004) p63 and p73: roles in development and tumor formation. Mol Cancer Res 2:371\u2013386","journal-title":"Mol Cancer Res"},{"key":"117_CR43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3171\/JNS-07\/08\/0398","volume":"107","author":"Y Nakane","year":"2007","unstructured":"Nakane Y, Natsume A, Wakabayashi T et al (2007) Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1AJ. Neurosurgery 107:398\u2013404","journal-title":"Neurosurgery"},{"key":"117_CR44","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1158\/1078-0432.CCR-08-0347","volume":"14","author":"PE Leone","year":"2008","unstructured":"Leone PE, Walker BA, Jenner MW et al (2008) Deletions of CDKN2C in multiple myeloma: biological and clinical implications. Clin Cancer Res 14:6033\u20136041","journal-title":"Clin Cancer Res"},{"key":"117_CR45","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","volume":"159","author":"J Bostr\u00f6m","year":"2001","unstructured":"Bostr\u00f6m J, Meyer-Puttlitz B, Wolter M et al (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661\u2013669","journal-title":"Am J Pathol"},{"key":"117_CR46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/gcc.20621","volume":"48","author":"M Kirsch","year":"2009","unstructured":"Kirsch M, M\u00f6rz M, Pinzer T et al (2009) Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas. Genes Chromosom Cancer 48:143\u2013154","journal-title":"Genes Chromosom Cancer"},{"key":"117_CR47","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.510270414","volume":"27","author":"A Iolascon","year":"1998","unstructured":"Iolascon A, Giordani L, Moretti A et al (1998) Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma. Hepatology 27:989\u2013995","journal-title":"Hepatology"},{"key":"117_CR48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1203\/00006450-199801000-00021","volume":"43","author":"A Iolascon","year":"1998","unstructured":"Iolascon A, Giordani L, Moretti A et al (1998) Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma. Pediatr Res 43:139\u2013144","journal-title":"Pediatr Res"},{"key":"117_CR49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/abio.2001.5570","volume":"303","author":"C Blanquicett","year":"2002","unstructured":"Blanquicett C, Johnson MR, Heslin M et al (2002) Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: applications in pharmacogenomic gene expression studies. Anal Biochem 303:209\u2013214","journal-title":"Anal Biochem"},{"key":"117_CR50","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.bbrc.2003.11.177","volume":"313","author":"A Radonic","year":"2004","unstructured":"Radonic A, Thulke S, Mackay IM et al (2004) Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313:856\u2013862","journal-title":"Biochem Biophys Res Commun"},{"key":"117_CR51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/514866","volume":"61","author":"D Antic","year":"1997","unstructured":"Antic D, Keene JD (1997) Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet 61:273\u2013278","journal-title":"Am J Hum Genet"},{"key":"117_CR52","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/hipo.20442","volume":"18","author":"DC Tanner","year":"2008","unstructured":"Tanner DC, Qiu S, Bolognani F et al (2008) Alterations in mossy fiber physiology and GAP-43 expression and function in transgenic mice overexpressing HuD. Hippocampus 18:814\u2013823","journal-title":"Hippocampus"},{"key":"117_CR53","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1073\/pnas.0407523102","volume":"102","author":"W Akamatsu","year":"2005","unstructured":"Akamatsu W, Fujihara H, Mitsuhashi T et al (2005) The RNA-binding protein HuD regulates neuronal cell identity and maturation. PNAS 102:4625\u20134630","journal-title":"PNAS"},{"key":"117_CR54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2009.03.022","volume":"67","author":"V D\u2019Alessandro","year":"2010","unstructured":"D\u2019Alessandro V, Muscarella LA, la Torre A et al (2010) Molecular analysis of the HuD gene in neuroendocrine lung cancers. Lung Cancer 67:69\u201375","journal-title":"Lung Cancer"},{"key":"117_CR55","first-page":"55","volume":"26","author":"KJ Choi","year":"2011","unstructured":"Choi KJ, Lee JH, Kim KS et al (2011) Identification of ELAVL4 as a modulator of radiation sensitivity in A549 non-small cell lung cancer cells. Oncol Rep 26:55\u201363","journal-title":"Oncol Rep"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-012-0117-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-012-0117-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-012-0117-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T17:00:39Z","timestamp":1687712439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-012-0117-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,11]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["117"],"URL":"https:\/\/doi.org\/10.1007\/s10014-012-0117-x","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,11]]}}}